Close Menu

NEW YORK (GenomeWeb) – Life sciences tools provider LGC said today that it has acquired Link Technologies, a supplier of specialty reagents for oligonucleotide synthesis.

Following the acquisition, LGC plans to form a new Nucleic Acid Chemistry business unit within its Genomics division that combines Link with its existing Biosearch oligo reagent group and Prime Synthesis CPG business.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.